U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07902934) titled 'Safety of NRICM301 Added to Standard Care in Adults With Acute Ischemic Stroke' on Oct. 21.
Brief Summary: This study will examine the short-term safety and tolerability of NRICM301, a food-grade herbal formula also known as Taiwan Xingnao No. 1, when added to standard care for adults hospitalized with acute ischemic stroke. An ischemic stroke occurs when blood flow to part of the brain is blocked.
The study will enroll up to 45 adults at Tri-Service General Hospital in Taiwan. Participants will be randomly assigned to receive either NRICM301 or a matching placebo for 14 days. Both groups will continue to receive standard stroke ca...